Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. USO
2. SPY
3. QTTB
4. BIIB
5. ERAS
6. PSKY
7. AAPL
8. JPM
9. NFLX
10. MU

Go back to Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab)
Amgen Inc (NASDAQ: AMGN) Delayed: 360.45 -2.94 (0.81%)
Previous Close $363.39    52 Week High $176.85 
Open $363.04    52 Week Low $133.64 
Day High $363.29    P/E 54.28 
Day Low $355.73    EPS $6.64 
Volume 2,064,618